Skip to main content
Glite Dictionary
rituximab

rituximab

3 8.1
A medicine made from antibodies that treats some cancers and autoimmune diseases
  • noun
  • /rɪˈtʌksɪˌmæb/
  • Specialized
: rituximab
  • The patient's treatment involved infusions of rituximab, a monoclonal antibody that targets specific cells in the immune system.
  • rituximab infusion
  • rituximab for rheumatoid arthritis
  • rituximab for rheumatoid

I'll have one last scan to see how much those have gone down due to the rituximab.

Examples

  • Rituximab, the chimeric monoclonal antibody, is directed against B cell surface membrane protein CD20.

    Academic text (2006)

  • The therapeutic efficacy of rituximab clearly supports the role of B cells in driving the NMO inflammatory process.

    Blog text (30)

  • Of the 30 patients, 28 showed a marked reduction in relapse following rituximab treatment over 24 months.

    Blog text (30)

  • Of 30 patients, 28 showed a marked reduction in relapse rate while taking rituximab over 24 months.

    Blog text (30)

  • A significant reduction in anti-AQP4-Ab levels was observed following rituximab treatment, consistent with the clinical response.

    Blog text (30)

  • The patient quickly stabilized, and the rituximab infusion was continued.

    Academic text (2006)

  • In previous NMO studies, a single cycle of rituximab appeared to be insufficient to suppress disease activity.

    Blog text (30)

  • Further long-term consequences of repeated rituximab therapy in patients with NMO are unknown.

    Blog text (30)

  • The patient's treatment involved infusions of rituximab, a chimeric monoclonal antibody that is directed against B cell surface membrane protein CD20.

    Academic text (2006)

  • Pre-emptive therapy with rituximab was initiated upon documentation of two consecutive plasma EBV DNA loads exceeding 1,000 copies/mL.

    Academic text (2018)

Surface Forms

rituximab singular
rituximabs plural

Morphology

rituximab = ritux + mab

The word is a proprietary/INN drug name built from an arbitrary stem 'ritux' plus the specialized biomedical suffix '-mab' (monoclonal antibody), so a typical learner cannot infer its meaning from the parts.

Etymology

Rituximab is a drug name made of parts used for antibody medicines: the ending -mab means 'monoclonal antibody', the middle -tu- points to 'tumour' (cancer), and -xi- shows it is 'partly from mouse and partly from human'. So rituximab is a targeted antibody medicine used to treat certain cancers and autoimmune diseases.